Expression of CD44 in Human Lung Tumors

Cancer Research

Volumn 54, Issue 5, 1994, Pages 1381-1387

  Penno, Margaret B ^a   August, J Thomas ^a   Baylin, Stephen B ^a,b   Mabry, Mack ^b   Linnoila, R Ilona ^c   Lee, Valerie S ^a   Croteau, Deborah ^a   Yang, Xiao Ling ^a   Rosada, Cecilia ^a  

^a Department of Medicine ^*  (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HERMES ANTIGEN; TUMOR MARKER;

ANTIGEN EXPRESSION; ARTICLE; CARCINOMA CELL; CONTROLLED STUDY; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG CARCINOMA; ONCOGENE RAS; PRIORITY JOURNAL; PROTEIN LOCALIZATION;

ANTIGENS, CD44; ANTIGENS, SURFACE; BASE SEQUENCE; BRONCHI; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SMALL CELL; CARRIER PROTEINS; EPITHELIUM; GENES, RAS; HUMANS; LUNG; LUNG NEOPLASMS; METAPLASIA; MOLECULAR SEQUENCE DATA; PHENOTYPE; RECEPTORS, CELL SURFACE; RECEPTORS, LYMPHOCYTE HOMING; RNA SPLICING; RNA, MESSENGER; TRANSDUCTION, GENETIC; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL;

EID: 0028271337     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Goldstein, L.A., Zhou, D.F., Picker, L.J., et al. A human lymphocyte homing receptor, the hermes antigen, is related to cartilage proteoglycan core and link proteins. Cell, 56: 1063-1072, 1989.
2. Stamenkovic, I., Amiot, M., Pesando, J.M., and Seed, B. A lymphocyte molecule implicated in lymph node homing is a member of the cartilage link protein family. Cell, 56: 1057-1062, 1989.
3. Culty, M., Miyake, K., Kincade, P.W., et al. The hyaluronate receptor is a member of the CD44 (H-CAM) family of cell surface glycoproteins. J. Cell Biol., 111: 2765-2774, 1990.
4. Aruffo, A., Stamenkovic, I., Melnick, M., Underhill, C.B., and Seed, B. CD44 is the principal cell surface receptor for hyaluronate. Cell, 61: 1303-1313, 1990.
5. Miyake, K., Underhill, C.B., Lesley, J., and Kincade, P.W. Hyaluronate can function as a cell adhesion molecule and CD44 participates in hyaluronate recognition. J. Exp. Med., 172: 69-75, 1990.
6. Lesley, J., Schulte, R., and Hyman, R. Binding of hyaluronic acid to lymphoid cell lines is inhibited by monoclonal antibodies against Pgp. 1. Exp. Cell Res., 187: 224-233, 1990.
7. Lesley, J., Hyman, R., and Kincade, P.W. CD44 and its interactions with the extracellular matrix. Adv. Immunol., 54: 271-335, 1993.
8. Heider, K.H., Hofmann, M., Hors, E., et al. A human homologue of the rat metastasis-associated variant of CD44. J. Cell Biol., 120: 227-233, 1993.
9. Birch, M., Mitchell, S., and Hart, I.R. Isolation and characterization of human melanoma cell variants expressing high and low levels of CD44. Cancer Res., 51: 6660-6667, 1991.
10. Shtivelman, E., and Bishop, J.M. Expression of CD44 is repressed in neuroblastoma cells. Mol. Cell. Biol., 11: 5446-5453, 1991.
11. Kalemkerian, G.P., and Mabry, M. Cellular and molecular biology of small-cell lung cancer. In: J.A. Roth, J.D. Cox, and W.K. Hong (eds.), Lung Cancer, pp. 57-84. Boston: Blackwell Scientific Publications, 1993.
12. Carney, D.N., Gazdar, A.F., Bepler, G., et al. Establishment and identification of small cell lung cancer cell lines having classic and variant features. Cancer Res., 45: 2913-2923, 1985.
13. Gazdar, A.F., Carney, D.N., Nau, M.M., and Minna, J.D. Characterization of variant subclasses of cell lines derived from small cell lung cancer having distinctive biochemical, morphological, and growth properties. Cancer Res., 45: 2924-2930, 1985.
14. Mitsudomi, T., Viallet, J., Mulshine, J.L., Linnoila, R.I., Minna, J.D., and Gazdar, A.F. Mutations of ras genes distinguish a subset of non-small-cell lung cancer cell lines from small-cell lung cancer cell lines. Oncogene, 6: 1353-1362, 1991.
15. Kurzrock, R., Gallick, G.E., and Gutterman, J.U. Differential expression of p. 1 ras gene products among histological subtypes of fresh primary human lung tumors. Cancer Res., 46: 1530-1534, 1986.
16. van de Rodenhuis, S., et al Mutational activation of the K-ras oncogene. A possible pathogenetic factor in adenocarcinoma of the lung. N. Engl. J. Med., 317: 929-935, 1987.
17. Doyle, L.A., Mabry, M., Stahel, R.A., Waibel, R., and Goldstein, L.H. Modulation of neuroendocrine surface antigens in oncogene-activated small cell lung cancer lines. Br. J. Cancer (Suppl.), 14: 39-42, 1991.
18. Mabry, M., Nelkin, B.D., Falco, J.P., Barr, L.E., and Baylin, S.B. Transitions between lung cancer phenotypes-implications for tumor progression. Cancer Cells, 3: 53-58, 1991.
19. Mabry, M., Nakagawa, T., Nelkin, B.D., et al v-Ha-ras oncogene insertion: a model for tumor progression of human small cell lung cancer. Proc. Natl. Acad. Sci. USA, 85: 6523-6527, 1988.
20. Falco, J.P., Baylin, S.B., Lupu, R., et al v-rasH induces non-small cell phenotype, with associated growth factors and receptors, in a small cell lung cancer cell line. J. Clin. Invest., 85: 1740-1745, 1990.
21. Sorenson, G.D., Pettengill, O.S., Brinck, J.T., Cate, C.C., and Maurer, L.H. Hormone production by cultures of small-cell carcinoma of the lung. Cancer (Phila.), 47: 1289-1296, 1981.
22. Griffin, C.A., and Baylin, S.B. Expression of the c-myb oncogene in human small cell lung carcinoma. Cancer Res., 45: 272-275, 1985.
23. Bergh, J., Nilsson, K., Zech, L., and Giovanella, B. Establishment and characterization of a continuous lung squamous cell carcinoma cell line (U-1752). Anticancer Res., 1: 317-322, 1981.
24. Belitsos, P.C., Hildreth, J.E., and August, J.T. Homotypic cell aggregation induced by anti-CD44 (Pgp. 1) monoclonal antibodies and related to CD44 (Pgp. 1) expression. J. Immunol., 144: 1661-1670, 1990.
25. Hughes, E.N., and August, J.T. Characterization of plasma membrane proteins identified by monoclonal antibodies. J. Biol. Chem., 256: 664-671, 1981.
26. Lin, S.L., Derr, D., and Hildreth, J.E. A monoclonal antibody against a novel 20-kDa protein induces cell adhesion and cytoskeleton-dependent morphologic changes. J. Immunol., 149: 2549-2559, 1992.
27. Scott, J.E. Secondary structures in hyaluronan solutions. In: The Biology of Hyaluronan, pp. 6-15. Ciba Foundation Symposium, Vol. 143, United Kingdom: Chichester, John Wiley & Sons, Inc., 1989.
28. Ausubel, F.M., Brent, R., Kingston, R.E., et al (eds.). Current Protocols in Molecular Biology. New York: Green Publishing Associated and Wiley-Interscience, 1988.
29. Chirgwin, J.M., Przybyla, A.E., MacDonald, R.J., and Rutter, W.J. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry, 18: 5294-5299, 1979.
30. Ponte, P., Ng, S.Y., Engel, J., Gunning, P., and Kedes, L. Evolutionary conservation in the untranslated regions of actin mRNAs: DNA sequence of a human β-actin cDNA. Nucleic Acids Res., 12: 1687-1696, 1984.
31. Linnoila, R.I., Mulshine, J.L., Steinberg, S.M., et al. Neuroendocrine differentiation in endocrine and nonendocrine lung carcinomas. Am. J. Clin. Pathol., 90: 641-652, 1988.
32. Linnoila, R.I., Mulshine, J.L., Steinberg, S.M., and Gazdar, A.F. Expression of surfactant-associated protein in non-small-cell lung cancer: a discriminant between biologic subsets. Natl. Cancer Inst. Monogr., 1992: 61-66, 1992.
33. Green, S.J., Tarone, G., and Underhill, C.B. Distribution of hyaluronate and hyaluronate receptors in the adult lung. J. Cell Sci., 89: 145-156, 1988.
34. Underhill, C.B., Nguyen, H.A., Shizari, M., and Culty, M. CD44 positive macrophages take up hyaluronan during lung development. Dev. Biol., 155: 324-336, 1993.
35. Sy, M.S., Guo, Y.J., and Stamenkovic, I. Distinct effects of two CD44 isoforms on tumor growth in vivo. J. Exp. Med., 174: 859-866, 1991.
36. Thomas, L., Byers, H.R., Vink, J., and Stamenkovic, I. CD44H regulates tumor cell migration on hyaluronate-coated substrate. J. Cell Biol., 118: 971-977, 1992.
37. Lee, S.J., and Hong, W.K. Biology of preneoplastic lesions. In: J.A. Roth, J.D. Cox, and W.K. Hong (eds.), Lung Cancer, pp. 34-56. Boston: Blackwell Scientific Publications, 1993.
38. Black, H., and Ackerman, L. Importance of epidermoid carcinoma in situ in histogenesis of carcinoma of the lung. Ann. Surg., 136: 44-55, 1952.
39. Weller, R. Metaplasia of bronchial epithelium: a postmortem study. Am. J. Clin. Pathol., 23: 768-774, 1953.
40. Hofmann, M., Rudy, W., Gunthert, U., et al A link between ras and metastatic behavior of tumor cells: ras induces CD44 promoter activity and leads to low-level expression of metastasis-specific variants of CD44 in CREF cells. Cancer Res., 53: 1516-1521, 1993.
41. Kiefer, P.E., Wegmann, B., Bacher, M., Erbil, G, Heidtmann, H., and Havemann, K. Different pattern of expression of cellular oncogenes in human non-small-cell lung cancer cell lines. J. Cancer Res. Clin. Oncol., 116: 29-37, 1990.
42. Bos, J.L. The ras gene family and human carcinogenesis. Mutat. Res., 195: 255-271, 1988.
43. Kiefer, P.E., Bepler, G., Kubasch, M., and Havemann, K. Amplification and expression of protooncogenes in human small cell lung cancer cell lines. Cancer Res., 47: 6236-6242, 1987.
44. Mulshine, J.L., Linnoila, R.I., Treston, A.M., et al. Candidate biomarkers for application as intermediate end points of lung carcinogenesis. J. Cell. Biochem. (Suppl.), 16G: 183-186, 1992.